Form D · Biotechnology

IMAGINAB, INC.

Inglewood, CA · CIK 0001545875

Offering snapshot reported Sep 15, 2017 · SEC filing

Reported sold
$7.67M
Offering amount: $12M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 5, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 15, 2017Initial$7,672,316No comparison6SEC filing
Apr 14, 2016Initial$5,341,245No comparison4SEC filing
Jul 9, 2014Initial$15,562,497No comparison5SEC filing
Apr 2, 2012Initial$7,250,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-294823

Source: Form D, filed Sep 15, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeff Bailey Director
Christian Behrenbruch Director, Executive
Isaac Bright Director
Valerie Calenda Director
Abbie Celniker Director
Benjamin Chen Executive
Martyn Coombs Director, Executive
Richard Ding Director
K. Leonard Judson Director
Jennifer Keppler Executive
Joseph Limber Director
Campbell Murray Director
Jeffrey D. Quan Executive
Thilo Schroeder Director
Anna W. Work Director
Anna M. Wu Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
423 Hindry Avenue Suite D
Inglewood, CA, 90301